Tagged: AVR

GlaxoSmithKline and Pfizer combine HIV-drug business

Law Professor Kevin Outterson, director of the Health Law Program, says big pharma giants GlaxoSmithKline and Pfizer combining their HIV-drug business should be good for the companies and for patients around the globe. “The joint venture will allow GSK and Pfizer to coordinate antiretroviral-drug research, which will both lower R&D costs and reduce competition between […]